Hansoh Pharmaceutical Group Company Limited
3KY.F·Frankfurt·Healthcare
3.5840−0.1150 (−3.11%)today
As of Oct 27, 3:25 PM CET · May be delayed up to 15 min · EUR
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close3.6990
Open3.5550
Day range3.55503.5840
52-week range3.09304.8000
Off day high0.00%
Off 52-week high−25.33%
Volume1.11K
Avg. volume (3M)88.00
Market cap21.73B
EPS (TTM)0.1300
Forward P/E—
P/E ratio (TTM)27.57
Dividend yield1.48% (0.0500)
Beta (5Y)0.54
Shares outstanding6.06B
Short interest—
Earnings dateAug 26, 2026
Analyst target—
Profit margin42.01%
Against its peers
Compare in full ›| 3KY.F | 3320.HK | 000623.SZ | 600664.SS | 000999.SZ | 000661.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 21.73B | 28.96B | 20.08B | 13.35B | 41.39B | 29.30B |
| P/E (TTM) | 27.6 | 6.2 | 6.2 | 26.5 | 12.5 | — |
| Forward P/E | — | 5.5 | 7.7 | 17.7 | 10.8 | 6.5 |
| Price/book | 4.3 | 0.5 | 0.6 | 2.3 | 1.8 | 1.3 |
| Dividend yield | 1.48% | 5.23% | 2.92% | — | 4.01% | 0.22% |
| 1-year change | −1.62% | −7.19% | −18.05% | +49.86% | −14.24% | −36.75% |
| Today | −3.11% | +0.55% | −1.93% | −3.64% | −0.72% | −2.23% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All 3KY.F news ›Rx Rundown: Merck KGaA, GSK, Hansoh Pharmaceutical and more
Check out this week’s medical marketing news, dealmaking and industry chatter. Merck KGaA said it would acquire Silence Therapeutics in an all-cash deal valued at approximately $1.3 billion. Hansoh Pharmaceutical subsidiaries entered into…
From articles in the 4Search news index.
In the news
2mentions in 30 days
2with it in the headline
Mixedsentiment
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com1
-
mmm-online.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.